全文获取类型
收费全文 | 9615篇 |
免费 | 613篇 |
国内免费 | 219篇 |
专业分类
耳鼻咽喉 | 207篇 |
儿科学 | 86篇 |
妇产科学 | 51篇 |
基础医学 | 1793篇 |
口腔科学 | 175篇 |
临床医学 | 938篇 |
内科学 | 2326篇 |
皮肤病学 | 370篇 |
神经病学 | 716篇 |
特种医学 | 473篇 |
外科学 | 983篇 |
综合类 | 78篇 |
现状与发展 | 1篇 |
预防医学 | 361篇 |
眼科学 | 121篇 |
药学 | 939篇 |
中国医学 | 171篇 |
肿瘤学 | 658篇 |
出版年
2024年 | 7篇 |
2023年 | 86篇 |
2022年 | 312篇 |
2021年 | 490篇 |
2020年 | 212篇 |
2019年 | 271篇 |
2018年 | 322篇 |
2017年 | 229篇 |
2016年 | 362篇 |
2015年 | 457篇 |
2014年 | 568篇 |
2013年 | 613篇 |
2012年 | 1053篇 |
2011年 | 934篇 |
2010年 | 489篇 |
2009年 | 406篇 |
2008年 | 520篇 |
2007年 | 534篇 |
2006年 | 411篇 |
2005年 | 389篇 |
2004年 | 278篇 |
2003年 | 271篇 |
2002年 | 223篇 |
2001年 | 181篇 |
2000年 | 176篇 |
1999年 | 135篇 |
1998年 | 72篇 |
1997年 | 64篇 |
1996年 | 44篇 |
1995年 | 33篇 |
1994年 | 45篇 |
1993年 | 21篇 |
1992年 | 28篇 |
1991年 | 24篇 |
1990年 | 31篇 |
1989年 | 22篇 |
1988年 | 23篇 |
1987年 | 14篇 |
1986年 | 17篇 |
1985年 | 15篇 |
1984年 | 9篇 |
1983年 | 5篇 |
1982年 | 4篇 |
1981年 | 5篇 |
1979年 | 6篇 |
1978年 | 4篇 |
1977年 | 13篇 |
1976年 | 6篇 |
1973年 | 2篇 |
1970年 | 2篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
11.
Hideaki Iwaki Kazuyoshi Johnin Susumu Kageyama Chul Jang Kim Takahiro Isono Tatsuhiro Yoshiki 《International journal of urology》2007,14(10):918-923
OBJECTIVES: Vesicoureteral reflux (VUR) is the most common congenital urinary tract anomaly. This disease can pose a major threat to the kidneys as twenty percent of patients with endstage renal disease are reported to have VUR. Although genetic studies for uroplakin III (UPIII) have been reported recently, no study has focused on UPIII gene expression in VUR patients. We describe here the up-regulation of UPIII mRNA in exfoliated urinary cells from primary VUR patients. METHODS: A real-time RT-PCR for UPIII mRNA was performed on exfoliated urothelial cells from 18 primary VUR and 38 control samples. UPIII mRNA copies were calculated for each sample. The statistical differences were assessed by the Mann-Whitney U test. Receiver operator characteristic curves were constructed for analysis of the diagnostic values. RESULTS: UPIII mRNA was found to be up-regulated to a greater extent in VUR than in control exfoliated urinary cells (mean +/- SE: 497.0 +/- 178.5 copies vs. 69.0 +/- 10.0 copies, respectively, P < 0.001). In evaluating the measurement of urinary UPIII mRNA as a screening test for VUR, the sensitivity was 77.8% and the specificity was 76.3% by the best diagnostic cutoff point. CONCLUSIONS: This is the first report demonstrating up-regulation of UPIII in mRNA levels in VUR patients. We submit that the quantitative measurement of urinary UPIII mRNA has a potential of developing into the first non-invasive screening test for VUR. 相似文献
12.
13.
14.
15.
16.
B Denise Raynor Elizabeth A Bonney Kyung T Jang Wendy Coto Meera S Garcia 《Hypertension in pregnancy》2004,23(2):129-134
Several parallels exist between preeclampsia and atherosclerosis. Both are multifactorial diseases that share risk factors such as obesity, insulin resistance, lipid abnormalities, and elevated serum homocysteine. There are also similarities in the biochemical changes seen in both diseases, including elevated serum triglycerides, decreased HDL cholesterol and enhanced formation of small, dense LDL particles as well as vascular atherosclerotic lesions. Chronic infection with Chlamydia pneumoniae has been linked to coronary artery disease. This study evaluated a possible link between the incidence of preeclampsia and infection with C. pneumoniae by examining the rate of seropositivity in 81 women with preeclampsia, and 206 women with normal pregnancies. Although our data confirmed well-known risk factors for preeclampsia such as obesity, diabetes, and hypertension, we found no difference in the rate of seropositivity between preeclampsia and normal pregnancy. On the contrary, the presence of chlamydial antibodies was lower in preeclampsia. Multiparous women with preeclampsia showed a significantly lower rate of seropositivity than multiparous normal women and nulliparous preeclamptics. In addition, women with a history of preeclampsia who developed preeclampsia in the current pregnancy also had a significantly lower rate of seropositivity. 相似文献
17.
18.
19.
Yun Jeong Lim Young-Ho Kim Geung Hwan Ahn Ho Kwung Chun Woo Young Jang Jun Haeng Lee Hee Jung Son Poong-Lyul Rhee Jae J Kim Seung Woon Paik Byung Chul Yoo Jong Chul Rhee 《Taehan Sohwagi Hakhoe chi》2004,44(6):314-320
BACKGROUND/AIMS: Carcinogenesis is characterized by the abnormal regulation of cell cycle. The abnormal expression of the regulators of cell cycle may be related to the prognosis. Since the clinical significance of the expression of the three proteins in colorectal carcinomas is still controversial, we evaluated the prognostic value of the expression of cyclin E, p27 and mutant p53 in stage II colorectal cancer. METHODS: The expression levels of cyclin E, p27 and mutant p53 proteins in 41 patients with stage II colorectal carcinomas were analyzed by immunohistochemistry. RESULTS: In the univariate analysis, the level of CEA at diagnosis was associated with disease relapse. In the multivariate analysis, the clinicopathological variables such as age, gender, site of primary tumor, tumor size, state of tumor differentiation and preoperative plasma CEA level were not associated with disease relapse. When Kaplan-Meier survival curves were constructed to determine the prognosis, cyclin E, p27 and mutant p53 expressions did not predict poor prognosis. CONCLUSIONS: Our results suggested that the expression of cyclin E, p27 and mutant p53 proteins did not predict the clinical outcome in the stage II colorectal carcinomas. 相似文献
20.
The Role of Donor Bone Marrow Infusions in Withdrawal of Immunosuppression in Adult Liver Allotransplantation 总被引:3,自引:0,他引:3
Panagiotis Tryphonopoulos reas G. Tzakis Debbie Weppler Rolando Garcia-Morales Tomoaki Kato Juan R. Madariaga David M. Levi Seigo Nishida Jang Moon Gennaro Selvaggi Arie Regev Caio Nery Pablo Bejarano Amr Khaled Gary Kleiner Violet Esquenazi Joshua Miller Philip Ruiz Camillo Ricordi 《American journal of transplantation》2005,5(3):608-613
We investigated the role of donor bone marrow cell (DBMC) infusions in immunosuppression withdrawal in adult liver transplantation. Patients enrolled were at least 3 years post-transplantation, with stable graft function. Forty-five (study group: G1) received DBMC, and 59 (control group: G2) did not. Immunosuppression was reduced by one third upon enrollment, by another third the second year of the study and was completely withdrawn the third year. Patient and graft survival were similar between the two groups. Although rejection episodes were significantly less in G1 the first 2 years of the study (35% vs. 57%, p = 0.016), there was no significant difference overall (74% vs. 81%, p = 0.14). Until February 2004, 20 patients, 10 in each group, were immunosuppression free for 1-3 years. Approximately 20% of long-term survivors of liver transplantation can successfully discontinue their immunosuppression. DBMC infusions, do not increase this likelihood. 相似文献